Get started Log in

NEWBRY — Newbury Pharmaceuticals AB Share News

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Market Cap
SEK63.23m
Enterprise Value
SEK48.55m
Revenue
SEK31.57m

Brief: Newbury Pharmaceuticals Q3 EBITDA Loss Widens To SEK 3.9 Mln
14/06/2023 07:11
Brief: Pirfenidone Newbury Gets Approved By Norwegian Health Authorities
12/05/2023 07:45
Brief: Newbury Pharmaceuticals Q2 EBITDA Loss Widens To SEK 4.6 Mln
12/04/2023 07:20
Brief: Lapatinib Newbury Gets Approved By Swedish Health Authorities
24/03/2023 11:04
Brief: Newbury Pharmaceuticals Says Dimethyl Fumarate Newbury Approved By Swedish Health Authorities
06/03/2023 14:00
Brief: Newbury Pharmaceuticals Adds Buspirone Tablets To Its Portfolio
02/02/2023 06:57
Brief: Newbury Pharmaceuticals Q1 2022 EBITDA Loss Widens To SEK 5.4 Mln
11/01/2023 08:16
Brief: Newbury Pharmaceuticals: Fampridine Newbury Approved By Swedish Health Authorities
27/12/2022 09:04
Brief: Newbury Expands Its Portfolio With Two Ready To Launch Products
23/11/2022 09:24
Brief: Newbury Pharmaceuticals Q4 EBITDA Loss Widens To SEK 3.6 Mln
13/10/2022 10:47
Brief: Newbury Q3 EBITDA Loss Widens To SEK 3.1 Mln
06/07/2022 07:08
Brief: Newbury Pharmaceuticals Q2 EBITDA Loss Widens To SEK 3.4 Mln
13/04/2022 07:06
Brief: Newbury Says Sunitinib Approved In Denmark
29/03/2022 15:31
Brief: Newbury Pharmaceuticals Lenalidomide Approved By The Swedish Health Authorities
07/03/2022 08:32
Brief: Newbury Pharmaceuticals Subsidiary Gets Export Order
07/02/2022 09:07